Esperion Therapeutics Inc... (ESPR)

ESPR trades at $3.3, 32.0% above the near-term max pain of $2.5 expiring Oct 17, 2025 (11 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($1-$6284.9), reflecting growing call interest at higher strikes. Key magnetic zone at 2 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ESPR shows an upward trend from 1 to 6284.9, suggesting bullish positioning in longer-dated options. The 798% spread signals divergent expectations across timeframes. Most levels below 3.3 may cap rallies. Strong magnetic level at 2 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.